It has been reported that TGP could promote re-pigmentation in vitiligo patients by improving the CD4+/CD8+ T lymphocyte ratio and the CD4+CD25+ Treg level in peripheral blood (Ye et al., 2013; Shen et al., 2019). The gene discussed is CD8A; the disease is vitiligo.